Atlas
Market PulseMovers & ShakersSector ViewStocksETFFundsPortfoliosAdmin
Atlas › Stocks › LENSKART

LENSKART

Lenskart Solutions Limited
Large-capHealthcare ↗

What the six lenses say about LENSKART — its relative strength vs the baselines, price & RS trend, the 8-quarter financials, and live filings.

Price
₹688.0
2026-09-08
VWAP · 1Y anchor
₹515
+33.6% from VWAP
P/E · TTM
175.1×
TTM EPS ₹3.9
52-week range
100%
position low→high
RSI(14)
78
momentum

Own sector index

Healthcare ↗
Neutral

1M

-1.1%

3M

+7.1%

1Y

+14.5%

Breadth >EMA21

55%

How LENSKART’s own sector index is moving — context for reading the stock’s six lenses.

Six-lens read

What the six lenses say

How the lenses are scored ↗
Strength
7.0
avg conviction decile
Leadership
Leader
top-decile composite in cohort
Each lens is a decile within its cap cohort (D10 = top 10%) — no black-box composite. Expand a lens for the real numbers behind it.
LensDecile · Large-cap cohortDRaw
TechnicalD10100›

The actual numbers

Price vs VWAP (1y)+33.6%
EMA trend stackUp · 21>50>200
Price vs 200-EMA+35.0%
Price vs 50-EMA+14.4%
RSI(14)78
RS vs Nifty 500 · 3M+31.9%
RS vs sector · 3M+29.2%
52-week range100%
Volume vs 30d avg0.34×
Volume vs 60d avg0.44×
ATR(14) · volatility22.2
Bollinger width · vol contraction0.174
FundamentalD132›

The actual numbers

Return on equity (ROE)6.9%
Return on capital (ROCE)8.4%
Operating margin9.7%
Net margin5.7%
Debt / equity0.35×

Full 8-quarter history in the financials table below.

ValuationD10›

The actual numbers

P/E (TTM)175.1×
TTM EPS₹3.9
52-week range100%
CatalystD649›

The actual numbers

Earnings & momentum24
Capital actions69
Governance99

Every filing in the corporate-announcements panel below.

FlowD450›

The actual numbers

Promoter holding17.6%
Delivery · 30d avg56.9%
Up/down-day asymmetry2.1pp
How the decile & conviction are calculated

Decile — each lens’s 0–100 score is ranked against every Large-cap stock in the universe. D10 = top 10% (strongest), D1 = bottom 10%. A decile is simply where this stock sits versus its size-peers on that lens — no weighting, no black box.

Conviction — the average of the two active conviction-lens deciles (Technical & Flow):

( D10 + D4 ) ÷ 2 = 7.0(Technical · Flow)

Fundamental, Catalyst, Valuation and Policy are shown for context but carry weight 0 in the current model, so they are not scored into conviction. Full detail on the methodology page ↗.

Glass box

How the score is built

Click a lens to expand its sub-components, then drill to the actual values. The eye icon on any term explains it.

Conviction score · Highest
95
Conviction score 95/100 · avg-decile strength 7.0/10
Conviction score95/100›
TechnicalD10›
FundamentalD1›
ValuationD1›
CatalystD6›
FlowD4›

Policy

Government policy · Healthcare

Active policies relevant to this sector — flagged as a Red / Amber / Green signal, not scored into the six-lens conviction. The lenses say what the market is doing; policy is context for why.

Tailwind· HIGH impact

PLI Scheme — Pharmaceuticals & API

Production-linked incentive scheme for pharmaceuticals, APIs, and medical devices

Relative strength · always on

Percentage-point spread vs each baseline across six windows. Green = outperforming, red = lagging. Data as of 2026-09-08.

Baseline1D1W1M3M6M12M
Nifty 50
Large-cap anchor
+0.9pp
+5.1pp
+25.2pp
+33.5pp
+35.0pp
—
Nifty 500
Broad-market baseline
+0.9pp
+5.1pp
+24.2pp
+31.9pp
+29.3pp
—
Sector
Own-sector index
—
—
+22.8pp
+29.2pp
+20.6pp
—

From atlas_foundation.technical_daily. Sector row covers 1M–12M (1D/1W not stored).

Trend

Price · EMA 20 / 50 / 200

LENSKART daily close with the three trend EMAs · atlas_foundation.ohlcv_stock.

₹ (close)
688.00+3.10

Relative strength

RS vs baseline · rebased to 100

LENSKART ÷ Nifty 500, rebased to 100 at window start — above 100 = outperforming since then.

RS vs Nifty 500 (=100)
173.93+1.51

TradingView composite technical analysis — multi-timeframe consensus

Quarterly financials

Last 8 quarters from the company’s filings (₹ crore) — revenue, profit, margins and the growth trend.

MetricSep '24Dec '24Mar '25Jun '25Sep '25Dec '25Mar '26
Revenue (₹cr)1,7361,6691,7281,8942,0962,3082,516
↳ change QoQ—-3.9%+3.5%+9.6%+10.7%+10.1%+9.0%
EBITDA (₹cr)286210292336413462536
EBITDA margin16.5%12.6%16.9%17.7%19.7%20.0%21.3%
PAT (₹cr)86222061103133204
↳ change QoQ—-97.7%+10900.0%-72.3%+68.9%+29.1%+53.4%
Net margin5.0%0.1%12.7%3.2%4.9%5.8%8.1%
EPS (₹)11.080.022.840.781.240.761.15
D/E———————
YoY growth · Mar '26Revenue +45.6% YoYPAT -7.3% YoY

Corporate announcements

Filings to the exchange — capital actions, earnings and governance. Most recent first.

  • 20 Aug '26
    LOWgovernance
    General Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 19 Aug '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 17 Aug '26
    HIGHcapital
    Acquisition
    ›

    An exchange filing — open the original disclosure on NSE for the full text.

    View original filing on NSE ↗
  • 13 Aug '26
    LOWgovernance
    Monitoring Agency Report
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 13 Aug '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 12 Aug '26
    LOWgovernance
    Options to purchase securities
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 12 Aug '26
    LOWgovernance
    General Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 12 Aug '26
    HIGHcapital
    Acquisition
    ›

    An exchange filing — open the original disclosure on NSE for the full text.

    View original filing on NSE ↗
  • 12 Aug '26
    HIGHcapital
    Acquisition
    ›

    An exchange filing — open the original disclosure on NSE for the full text.

    View original filing on NSE ↗
  • 12 Aug '26
    HIGHcapital
    Acquisition
    ›

    An exchange filing — open the original disclosure on NSE for the full text.

    View original filing on NSE ↗
  • 12 Aug '26
    LOWgovernance
    General Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 12 Aug '26
    HIGHearnings
    Outcome of Board Meeting
    ›

    An exchange filing — open the original disclosure on NSE for the full text.

    View original filing on NSE ↗
  • 5 Aug '26
    LOWgovernance
    Options to purchase securities
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 3 Aug '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 30 Jul '26
    LOWgovernance
    General Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗

…and 5 more.

Ownership

Who holds LENSKART

Mutual funds holding LENSKART (10)

FundWeightAUM ₹crGrade
SBI Equity Hybrid Fund Reg Gr1.47%88,036
Kotak Midcap Reg Gr1.25%69,283
Kotak Flexicap Reg Gr0.60%56,119
Mirae Asset Large & Midcap Gr0.97%45,275
Axis Midcap Gr1.68%34,404
Aditya BSL Large Cap Gr1.11%29,944
Aditya BSL Large Cap Gr Tr1.11%29,944
Aditya BSL Flexi Cap Gr1.57%28,112
Mirae Asset ELSS Tax Saver Reg Gr1.13%26,373
Canara Robeco Large & Mid Cap Reg Gr1.09%26,062

ETFs holding LENSKART (4)

ETFWeightGrade
Motilal Oswal BSE Select IPO ETF1.49%
Motilal Oswal Nifty Midcap 100 ETF0.55%
LIC MF Nifty Midcap 100 ETF0.54%
Mirae Asset BSE 200 Equal Weight ETF0.52%
Show company profile (about, sector, employees, IPO)
Native from atlas_foundation — lens journal, technical_daily, ohlcv_stock; TradingView for the live instrument view. ← Back to Healthcare